The ability to analyze gene expression at the single-cell level — known as single-cell RNA sequencing (scRNA-seq) — has ...

The Synthetic Human Genome, or Syn HG, a project launched on June 26th, aims to change that. Funded partly by Wellcome, a ...

Proteins are the infinitely varied chemicals that make cells work, and science has a pretty good idea how they are made. But ...

Many pressing medical challenges, such as diagnosing disease, enhancing directed stem-cell differentiation, and classifying cancers, have long been hindered by limitations in our ability to quantify ...

Avance Biosciences is proud to announce the launch of its Next-Generation Sequencing (NGS) Center of Excellence, a purpose-built facility designed to unify and enhance the company's sequencing ...

A landmark study by WEHI scientists has shed new light on one of the most fundamental mysteries of biology: how cells divide ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Q1 results, resolving litigation, but faces trade and NIH policy challenges. Click for my look at TXG stock prospects.

The cellular composition and underlying spatiotemporal transformation processes of subchondral bone in osteoarthritis (OA) remain unknown. Herein, various cell subsets from tibial plateau of patients ...

The AI unicorn's Perturb-seq atlas is publicly available and detects dose-dependent genetic effects to enhance predictive ...

The high-end cellomics market size has grown robustly in recent times, scaling from $2.90 billion in 2024 to $3.15 billion in 2025, marking a compound annual growth rate CAGR of 8.6%. The surge in ...